Boesen Biotech ApS: Financial statements 2023
CVR: 39142635
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Boesen Biotech ApS (CVR 39142635) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -28,051 and a net result of DKK -3,967,498 compared with DKK -5,462,889 the year before. Equity in the 2023 report amounted to DKK 732,902. The solvency ratio was 13.6%.
- Gross Profit
- DKK -28,051
- Profit/Loss
- DKK -3,967,498
- Equity
- DKK 732,902
- Total Assets
- DKK 5,393,943
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -28K | -4M | 733K | 0 |
| 2022 | - | -36K | -5.5M | 4.7M | - |
| 2021 | - | -34K | 8.1M | 10.2M | - |
| 2020 | - | -21K | 2.3M | 2.1M | - |
| 2019 | - | -14K | -2K | -227K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Boesen Biotech ApS has published its annual report for 2022. Gross profit came to DKK -36,461, and the net result was DKK -5,462,889.
About Boesen Biotech ApS
Boesen Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thomas Boesen. The company is owned by T. BOESEN HOLDING ApS and Gudter ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -54,998 and a net result of DKK 2,039,886 compared with DKK 723,812 the year before. Equity in the 2025 report amounted to DKK 3,496,600.